These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6425064)

  • 1. Deficiency of antithrombin III in children with hemolytic-uremic syndrome.
    Roth B; von Lilien T; Busch B; Gillor A; Bulla M
    Eur J Pediatr; 1984 Apr; 142(1):16-20. PubMed ID: 6425064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.
    Gillor A; Bulla M; Roth B; Bussmann K; Schrör K; Tekook A; Gladtke E
    Klin Wochenschr; 1983 Apr; 61(7):363-7. PubMed ID: 6345920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis in a child with the hemolytic-uremic syndrome.
    Kalmin ND; Himot ED
    Transfusion; 1983; 23(2):139-42. PubMed ID: 6836693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of plasma exchange in the treatment of severe forms of hemolytic-uremic syndrome in childhood.
    Slavicek J; Puretić Z; Novak M; Sarnavka V; Benjak V; Glavas-Boras S; Thune S
    Artif Organs; 1995 Jun; 19(6):506-10. PubMed ID: 8526789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-partum hemolytic uremic syndrome: treatment with plasma exchange.
    Gordon BR; Saal SD
    Clin Exp Dial Apheresis; 1983; 7(3):169-76. PubMed ID: 6671349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma infusion as treatment for 33 children with haemolytic uraemic syndrome: a good therapy?
    Brichard B; Vermylen C; Heremans MT; Ninane J; Cornu G
    Acta Clin Belg; 1993; 48(3):156-63. PubMed ID: 8396297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
    BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome. Results of treatment with hemodialysis.
    Ekberg M; Holmberg L; Denneberg T
    Acta Paediatr Scand; 1977 Nov; 66(6):693-8. PubMed ID: 411323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic uremic syndrome].
    Kowalik GO; Jóźwiak L; Ksiazek A
    Pol Arch Med Wewn; 2005 Dec; 114(6):1212-6. PubMed ID: 16789491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased plasma fibronectin levels in children with hemolytic-uremic syndrome.
    Cosio FG; Eddy A; Mentser MI; Bergstein JM
    Am J Med; 1985 Apr; 78(4):549-54. PubMed ID: 3885728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of plasmapheresis in the treatment of hemolytic-uremic syndrome in children].
    Salvatori G; Rinaldi S; Landolfo A; Totino T; Salvatori A; Signoretti A
    Pediatr Med Chir; 1986; 8(3):383-7. PubMed ID: 3786202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined plasmapheresis and hemodialysis treatment for severe hemolytic-uremic syndrome following Campylobacter colitis.
    Denneberg T; Friedberg M; Holmberg L; Mathiasen C; Nilsson KO; Takolander R; Walder M
    Acta Paediatr Scand; 1982 Mar; 71(2):243-5. PubMed ID: 7136632
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral gangrene complicating hemolytic uremic syndrome in a child.
    Ozel A; Calişkan U; Gücer S
    Pediatr Nephrol; 2003 May; 18(5):465-7. PubMed ID: 12736810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of hemolytic-uremic syndrome with development of catastrophic antiphospholipid syndrome: diagnosis and clinical tactics].
    Dzhumabaeva BT; Biriukova LS; Tsvetaeva NV; Sukhanova GA; Vasil'ev SA; Shavlokhov VS; Karagiulian SR; Kaplanskaia IB; Petrova VI; Avdonin PV
    Ter Arkh; 2010; 82(3):56-60. PubMed ID: 20564925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome.
    Bergstein JM; Riley M; Bang NU
    N Engl J Med; 1992 Sep; 327(11):755-9. PubMed ID: 1501651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Monteagudo J; Pereira A; Reverter JC; Pijoan J; Tusell J; Puig L; Ordinas A; Castillo R
    Thromb Haemost; 1991 Nov; 66(5):515-9. PubMed ID: 1803613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN
    Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation is associated with more severe course of diarrhea-associated hemolytic uremic syndrome, a preliminary study.
    Karnisova L; Hradsky O; Blahova K; Fencl F; Dolezel Z; Zaoral T; Zieg J
    Eur J Pediatr; 2018 Dec; 177(12):1837-1844. PubMed ID: 30251107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of hemolytic uremic syndrome after liver-kidney transplantation.
    Gatti S; Arru M; Reggiani P; Como G; Rossi F; Fassati LR; Ponticelli C
    J Nephrol; 2003; 16(4):586-90. PubMed ID: 14696763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.